Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders

Marandino, L., J.J. de Jong (Joep), Raggi, D., Gallina, A., Bandini, M., Giannatempo, P., Colecchia, M., A. Briganti (Alberto), F. Montorsi (Francesco), Davicioni, E., et al. Seiler, R., Black, P., A. Necchi (Andrea)

2020-10-01

Additional Metadata
Persistent URL	doi.org/10.1016/s0959-8049(20)31120-5, hdl.handle.net/1765/133790
Journal	European Journal of Cancer
Organisation	Department of Urology
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Marandino, L., de Jong, J., Raggi, D., Gallina, A., Bandini, M., Giannatempo, P., … Necchi, A. (2020). Molecular profiling of post-pembrolizumab muscle-invasive bladder cancer reveals unique features that may inspire new sequential therapies in nonresponders. European Journal of Cancer, 138. doi:10.1016/s0959-8049(20)31120-5

Publication